The Impact of Untreated Depression and Anxiety Among Patients With Skin Diseases in Jeddah, Saudi Arabia.
1 other identifier
observational
215
1 country
1
Brief Summary
The goal of this observational study is to learn about the prevalence and severity of untreated depression and anxiety among adults with skin diseases in Jeddah, Saudi Arabia. The main question it aims to answer is: Do patients with skin diseases experience significant levels of untreated depression and anxiety? Participants diagnosed with skin conditions such as acne, eczema, or psoriasis completed the PHQ-9 and GAD-7 questionnaires to assess their mental health symptoms. The study also explores whether factors like age or type of skin disease are associated with more severe psychological distress.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2024
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 29, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
July 29, 2024
CompletedFirst Submitted
Initial submission to the registry
June 23, 2025
CompletedFirst Posted
Study publicly available on registry
July 1, 2025
CompletedJuly 1, 2025
June 1, 2025
7 months
June 23, 2025
June 30, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Prevalence of untreated anxiety
The proportion of patients with dermatological conditions who score above the clinical threshold for anxiety on the Generalized Anxiety Disorder-7 (GAD-7) scale.
1 day (Assessed at one point in time during the study.)
Prevalence of untreated depression
The proportion of patients with dermatological conditions who score above the clinical threshold for depression on the Patient Health Questionnaire-9 (PHQ-9).
1 day (Assessed at one point in time during the study.)
Secondary Outcomes (1)
Correlation between skin disease severity and psychological distress
1 day (Assessed at one point in time during the study.)
Eligibility Criteria
The study population consists of adult patients aged 18 to 65 years residing in Jeddah, Saudi Arabia, who have been diagnosed with one or more of the following dermatological conditions: acne vulgaris, atopic dermatitis (eczema), psoriasis, vitiligo, rosacea, hidradenitis suppurativa, or alopecia areata. Participants were recruited from dermatology outpatient clinics and through online social media platforms.
You may qualify if:
- Adults aged 18 to 65 years
- Residents of Jeddah, Saudi Arabia
- Diagnosed with one or more of the following skin diseases: acne vulgaris, atopic dermatitis (eczema), psoriasis, vitiligo, rosacea, hidradenitis suppurativa, or alopecia areata
- Able to complete the study questionnaire in Arabic or English
You may not qualify if:
- Age below 18 or above 65 years
- Absence of diagnosis for the specified skin diseases
- Presence of chronic systemic illnesses such as diabetes, cardiovascular diseases, hypertension, or epilepsy
- Inability to provide informed consent or complete the questionnaire
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
King Abdulaziz University - Faculty of Medicine
Jeddah, Saudi Arabia
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Medical student Researcher
Study Record Dates
First Submitted
June 23, 2025
First Posted
July 1, 2025
Study Start
January 1, 2024
Primary Completion
July 29, 2024
Study Completion
July 29, 2024
Last Updated
July 1, 2025
Record last verified: 2025-06
Data Sharing
- IPD Sharing
- Will not share
Although aggregate study results will be published, individual participant data (IPD) will not be shared because no identifiable data was collected, ensuring participant privacy and confidentiality.